Tyson Carter
Foot & Ankle Surgery · Ogden, UTNPI 1578902896
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (51.8%), food and beverage and education — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Arthrex at 27.1% of the total. Reporting peaked in 2019 at $3,973 and has fallen 95.0% since, to $200 in 2025.
Across 47 payments — averaging $133.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2K
- Arthrosurface Incorporated$884
- Osteomed LLC$776
- Stryker$518
- Medical Device Business Services, Inc.$490
- Treace Medical Concepts, Inc.$430
- plus $1K from 10 others
What the payments were for
- Travel & lodging$3,26452%
- Food & beverage$2,17635%
- Education$85714%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 8 | $1,709 |
| Arthrosurface Incorporated | 8 | $884 |
| Osteomed LLC | 4 | $776 |
| Stryker | 5 | $518 |
| Medical Device Business Services, Inc. | 5 | $490 |
| Treace Medical Concepts, Inc. | 1 | $430 |
| Anika Therapeutics, Inc. | 1 | $322 |
| Active Medical, LLC | 1 | $213 |
| Sanara Medtech Inc. | 3 | $212 |
| Organogenesis Inc. | 3 | $155 |
| Bone Support Inc. | 1 | $145 |
| Heron Therapeutics, Inc. | 1 | $122 |
| Bioventus LLC | 1 | $116 |
| Imbed Biosciences Inc. | 1 | $81 |
| Fusion Orthopedics, LLC. | 1 | $68 |
| Orthofix Medical, Inc. | 3 | $55 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HemiCAP MTP Resurfacing$656
- EXT-Extremilock Foot$655
- EXT-ExtremiLock Ankle$655
- EXT-Staple$655
- EXT-ExtremiFix Midsize/Large$655
- Lapiplasty System$430
- VA-LCP PLATES & SCREWS$401
- Arthrosurface Hammertoes$322
- STAR$147
- TRAUMA$145
- CERAMENTBONE VOID FILLER$145
- CERAMENT G$145
- CellerateRx$139
- BIO-Osteovation (EXT)$136
- Zynrelef$122
- OsteoAMP$116
- PuraPly$100
How this compares
$6,297 in reported general payments places this provider in the 70th percentile of 104 foot & ankle surgery providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 36 | $636 |
| Diclofenac Sodium | 17 | $401 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Ogden
- Gregory AndersonSalt Lake City$1.6M
- Ryan RigbyLogan$975K
- Florian NickischSalt Lake City$474K
- Brian LiljenquistSalt Lake City$263K
- Douglas TooleSalt Lake City$258K
- Francis ClarkWest Jordan$125K
- David SeegmillerSalt Lake City$120K
- Scott ClarkWest Jordan$74K
- Riley RamptonProvidence$49K
- Gregory CookLogan$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.